Signaturefd, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Signaturefd, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$14.37 - $19.07 $445 - $591	-31 Reduced 3.18%	943 $16,000
Q2 2023 Aug 01, 2023	BUY	$10.44 - $16.48 $9,030 - $14,255	865 Added 793.58%	974 $13,000
Q1 2023 Apr 28, 2023	SELL	$10.7 - $15.79 $609 - $900	-57 Reduced 34.34%	109 $1,000
Q4 2022 Jan 27, 2023	SELL	$11.42 - $17.05 $3,083 - $4,603	-270 Reduced 61.93%	166 $2,000
Q3 2022 Nov 08, 2022	BUY	$9.76 - $13.41 $3,279 - $4,505	336 Added 336.0%	436 $6,000
Q2 2022 Aug 10, 2022	BUY	$7.6 - $11.41 $326 - $490	43 Added 75.44%	100 $1,000
Q1 2022 May 02, 2022	BUY	$9.3 - $12.37 $530 - $705	57 New	57 $1,000
Q4 2021 Jan 25, 2022	SELL	$10.39 - $15.15 $685 - $999	-66 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$11.39 - $16.23 $751 - $1,071	66 New	66 $1,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.